Head-to-head comparison of an intradermal and a virosome influenza vaccine in patients over the age of 60

References

• Weksler ME, Szabo P. The effect of age on the B-cell repertoire. J Clin Immunol 2000; 20:240 - 9; http://dx.doi.org/10.1023/A:1006659401385; PMID: 10939711
   PubMed Web of Science ®Google Scholar
• Deng Y, Jing Y, Campbell AE, Gravenstein S. Age-related impaired type 1 T cell responses to influenza: reduced activation ex vivo, decreased expansion in CTL culture in vitro, and blunted response to influenza vaccination in vivo in the elderly. J Immunol 2004; 172:3437 - 46; PMID: 15004143
   PubMed Web of Science ®Google Scholar
• Kovaiou RD, Herndler-Brandstetter D, Grubeck-Loebenstein B. Age-related changes in immunity: implications for vaccination in the elderly. Expert Rev Mol Med 2007; 9:1 - 17; http://dx.doi.org/10.1017/S1462399407000221; PMID: 17266794
   PubMedGoogle Scholar
• Renshaw M, Rockwell J, Engleman C, Gewirtz A, Katz J, Sambhara S. Cutting edge: impaired Toll-like receptor expression and function in aging. J Immunol 2002; 169:4697 - 701; PMID: 12391175
   PubMed Web of Science ®Google Scholar
• Goodwin K, Viboud C, Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006; 24:1159 - 69; http://dx.doi.org/10.1016/j.vaccine.2005.08.105; PMID: 16213065
   PubMed Web of Science ®Google Scholar
• Weinberger B, Herndler-Brandstetter D, Schwanninger A, Weiskopf D, Grubeck-Loebenstein B. Biology of immune responses to vaccines in elderly persons. Clin Infect Dis 2008; 46:1078 - 84; http://dx.doi.org/10.1086/529197; PMID: 18444828
   PubMed Web of Science ®Google Scholar
• de Jong JC, Beyer WE, Palache AM, Rimmelzwaan GF, Osterhaus AD. Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly. J Med Virol 2000; 61:94 - 9; http://dx.doi.org/10.1002/(SICI)1096-9071(200005)61:1<94::AID-JMV15>3.0.CO;2-C; PMID: 10745239
   PubMed Web of Science ®Google Scholar
• Carrat F, Flahault A. Influenza vaccine: the challenge of antigenic drift. Vaccine 2007; 25:6852 - 62; http://dx.doi.org/10.1016/j.vaccine.2007.07.027; PMID: 17719149
   PubMed Web of Science ®Google Scholar
• Baldo V, Baldovin T, Floreani A, Carraro AM, Trivello R, Family Medicine Group of Pianiga. MF59-adjuvanted influenza vaccine confers superior immunogenicity in adult subjects (18-60 years of age) with chronic diseases who are at risk of post-influenza complications. Vaccine 2007; 25:3955 - 61; http://dx.doi.org/10.1016/j.vaccine.2007.02.045; PMID: 17383057
   PubMed Web of Science ®Google Scholar
• Monto AS, Ansaldi F, Aspinall R, McElhaney JE, Montaño LF, Nichol KL, et al. Influenza control in the 21st century: Optimizing protection of older adults. Vaccine 2009; 27:5043 - 53; http://dx.doi.org/10.1016/j.vaccine.2009.06.032; PMID: 19559118
   PubMed Web of Science ®Google Scholar
• Ansaldi F, Canepa P, Parodi V, Bacilieri S, Orsi A, Compagnino F, et al. Adjuvanted seasonal influenza vaccines and perpetual viral metamorphosis: the importance of cross-protection. Vaccine 2009; 27:3345 - 8; http://dx.doi.org/10.1016/j.vaccine.2009.01.081; PMID: 19200846
   PubMed Web of Science ®Google Scholar
• Müller D, Szucs TD. Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05. Infection 2007; 35:308 - 19; http://dx.doi.org/10.1007/s15010-007-6218-5; PMID: 17885730
   PubMed Web of Science ®Google Scholar
• Blank PR, Schwenkglenks M, Szucs TD. Influenza vaccination coverage rates in five European countries during season 2006/07 and trends over six consecutive seasons. BMC Public Health 2008; 8:272; http://dx.doi.org/10.1186/1471-2458-8-272; PMID: 18673545
   PubMed Web of Science ®Google Scholar
• Hollmeyer HG, Hayden F, Poland G, Buchholz U. Influenza vaccination of health care workers in hospitals--a review of studies on attitudes and predictors. Vaccine 2009; 27:3935 - 44; http://dx.doi.org/10.1016/j.vaccine.2009.03.056; PMID: 19467744
   PubMed Web of Science ®Google Scholar
• Keeton VF, Chen AK. Immunization updates and challenges. Curr Opin Pediatr 2010; 22:234 - 40; http://dx.doi.org/10.1097/MOP.0b013e328337685b; PMID: 20125025
   PubMed Web of Science ®Google Scholar
• Reygrobellet C, Viala-Danten M, Meunier J, Weber F, Nguyen VH. Perception and acceptance of intradermal influenza vaccination: Patient reported outcomes from phase 3 clinical trials. Hum Vaccin 2010; 6:336 - 45; http://dx.doi.org/10.4161/hv.6.4.10753; PMID: 20372083
   PubMed Web of Science ®Google Scholar
• Arnou R, Frank M, Hagel T, Prébet A. Willingness to vaccinate or get vaccinated with an intradermal seasonal influenza vaccine: a survey of general practitioners and the general public in France and Germany. Adv Ther 2011; 28:555 - 65; http://dx.doi.org/10.1007/s12325-011-0035-z; PMID: 21626269
   PubMed Web of Science ®Google Scholar
• Eizenberg P, Booy R, Naser N, Mason G, Stamboulian D, Weber F. Acceptance of Intanza® 9 μg intradermal influenza vaccine in routine clinical practice in Australia and Argentina. Adv Ther 2011; 28:640 - 9; http://dx.doi.org/10.1007/s12325-011-0042-0; PMID: 21751080
   PubMed Web of Science ®Google Scholar
• Durando P, Alicino C, Alberti M, Sticchi L, Turello V, Marensi L, et al, Italian Intradermal Influenza Vaccine Working Group. Acceptance and safety of the intradermal influenza vaccine among the elderly in Italy: an on-field national study. Adv Ther 2012; 29:312 - 26; http://dx.doi.org/10.1007/s12325-012-0012-1; PMID: 22529024
   PubMed Web of Science ®Google Scholar
• Holland D, Booy R, De Looze F, Eizenberg P, McDonald J, Karrasch J, et al. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. J Infect Dis 2008; 198:650 - 8; http://dx.doi.org/10.1086/590434; PMID: 18652550
   PubMed Web of Science ®Google Scholar
• Arnou R, Icardi G, De Decker M, Ambrozaitis A, Kazek MP, Weber F, et al. Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study. Vaccine 2009; 27:7304 - 12; http://dx.doi.org/10.1016/j.vaccine.2009.10.033; PMID: 19849996
   PubMed Web of Science ®Google Scholar
• Van Damme P, Arnou R, Kafeja F, Fiquet A, Richard P, Thomas S, et al. Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study. BMC Infect Dis 2010; 10:134; http://dx.doi.org/10.1186/1471-2334-10-134; PMID: 20504306
   PubMed Web of Science ®Google Scholar
• Ansaldi F, Canepa P, Ceravolo A, Valle L, de Florentiis D, Oomen R, et al. Intanza(®) 15 mcg intradermal influenza vaccine elicits cross-reactive antibody responses against heterologous A(H3N2) influenza viruses. Vaccine 2012; 30:2908 - 13; http://dx.doi.org/10.1016/j.vaccine.2012.02.003; PMID: 22342501
   PubMed Web of Science ®Google Scholar
• Laurent PE, Bonnet S, Alchas P, Regolini P, Mikszta JA, Pettis R, et al. Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system. Vaccine 2007; 25:8833 - 42; http://dx.doi.org/10.1016/j.vaccine.2007.10.020; PMID: 18023942
   PubMed Web of Science ®Google Scholar
• Van Damme P, Oosterhuis-Kafeja F, Van der Wielen M, Almagor Y, Sharon O, Levin Y. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults. Vaccine 2009; 27:454 - 9; http://dx.doi.org/10.1016/j.vaccine.2008.10.077; PMID: 19022318
   PubMed Web of Science ®Google Scholar
• Gelinck LB, van den Bemt BJ, Marijt WA, van der Bijl AE, Visser LG, Cats HA, et al. Intradermal influenza vaccination in immunocompromized patients is immunogenic and feasible. Vaccine 2009; 27:2469 - 74; http://dx.doi.org/10.1016/j.vaccine.2009.02.053; PMID: 19368788
   PubMed Web of Science ®Google Scholar
• Chi RC, Rock MT, Neuzil KM. Immunogenicity and safety of intradermal influenza vaccination in healthy older adults. Clin Infect Dis 2010; 50:1331 - 8; http://dx.doi.org/10.1086/652144; PMID: 20377407
   PubMed Web of Science ®Google Scholar
• Frenck RW Jr., Belshe R, Brady RC, Winokur PL, Campbell JD, Treanor J, et al. Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults. Vaccine 2011; 29:5666 - 74; http://dx.doi.org/10.1016/j.vaccine.2011.06.010; PMID: 21699951
   PubMed Web of Science ®Google Scholar
• Esposito S, Daleno C, Picciolli I, Tagliaferri L, Scala A, Prunotto G, et al. Immunogenicity and safety of intradermal influenza vaccine in children. Vaccine 2011; 29:7606 - 10; http://dx.doi.org/10.1016/j.vaccine.2011.08.021; PMID: 21855592
   PubMed Web of Science ®Google Scholar
• Arnou R, Eavis P, Pardo JR, Ambrozaitis A, Kazek MP, Weber F. Immunogenicity, large scale safety and lot consistency of an intradermal influenza vaccine in adults aged 18-60 years: Randomized, controlled, phase III trial. Hum Vaccin 2010; 6:346 - 54; http://dx.doi.org/10.4161/hv.6.4.10961; PMID: 20372053
   PubMed Web of Science ®Google Scholar
• Committee for Proprietary Medicinal Products. (1997). Note for Guidance on Harmonisation of Requirements for Influenza Vaccines. CPMP/BWP/214/96. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003945.pdf.
   Google Scholar
• Zambon M. Laboratory diagnosis of influenza. In: Textbook of influenza. Edited by Nicholson KG, Webster RG, Hay AJ. Oxford: Blackwell Science; 1998:291–313.
   Google Scholar
• Rowe T, Abernathy RA, Hu-Primmer J, Thompson WW, Lu X, Lim W, et al. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol 1999; 37:937 - 43; PMID: 10074505
   PubMed Web of Science ®Google Scholar
• World Health Organization, Department of Communicable Disease Surveillance and Response, Global Influenza Programme. (2002): WHO manual on animal influenza diagnosis and surveillance. WHO/CDS/NCS/2002/5. http://whqlibdoc.who.int/hq/2002/WHO_CDS_CSR_NCS_2002.5.pdf.
   Google Scholar
• Ansaldi F, Bacilieri S, Amicizia D, Valle L, Banfi F, Durando P, et al. Antigenic characterisation of influenza B virus with a new microneutralisation assay: comparison to haemagglutination and sequence analysis. J Med Virol 2004; 74:141 - 6; http://dx.doi.org/10.1002/jmv.20157; PMID: 15258980
   PubMed Web of Science ®Google Scholar
• Beyer WEP, Palache AM, Lüchters G, Nauta J, Osterhaus ADME. Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination?. Virus Res 2004; 103:125 - 32; http://dx.doi.org/10.1016/j.virusres.2004.02.024; PMID: 15163500
   PubMed Web of Science ®Google Scholar